Division of Endocrinology and Metabolism, Department of Medicine, Kyung Hee University School of Medicine, Kyung Hee University Hospital at Gangdong, Korea.
Diabet Med. 2012 Sep;29(9):1165-70. doi: 10.1111/j.1464-5491.2012.03622.x.
The aim of this study was to investigate whether increased apolipoprotein B/apolipoprotein A-I ratio is associated with Type 2 diabetes mellitus independent of other risk factors for Type 2 diabetes.
A total of 70,063 subjects (41,391 men and 28,672 women; mean age 41.5 years) who visited the Health Screening Center at Kangbuk Samsung Hospital for a routine medical check-up between January 2009 and December 2009 were enrolled in this study.
The mean apolipoprotein B/apolipoprotein A-I ratio in the study subjects was 0.66 ± 0.18. The prevalence of Type 2 diabetes increased across the apolipoprotein B/apolipoprotein A-I ratio quartiles (1.0%, 1.6%, 2.9%, and 4.8% for the 1st through 4th quartiles, respectively, P < 0.001) and homeostasis model assessment-insulin resistance (HOMA2-IR) also showed an increasing tendency by quartile (P < 0.001). The apolipoprotein B/apolipoprotein A-I ratio was correlated with age, adiposity, blood pressure, HOMA2-IR value, fasting glucose levels, and other inflammatory marker, including high-sensitivity C-reactive protein, and lipoprotein (a) levels (all P < 0.001). In a multiple logistic regression model, the highest apolipoprotein B/apolipoprotein A-I ratio quartile was associated with Type 2 diabetes, even after controlling for other risk factors for diabetes, such as age, gender, BMI, systolic blood pressure, HOMA2-IR values, high-sensitivity C-reactive protein levels, family history of diabetes, presence of metabolic syndrome, and conventional lipid parameters (odds ratio 1.31; 95% confidence interval 1.17-1.46, P < 0.001).
The apolipoprotein B/apolipoprotein A-I ratio was found to be associated with Type 2 diabetes independent of other risk factors for diabetes and conventional lipid parameters.
本研究旨在探讨载脂蛋白 B/载脂蛋白 A-I 比值的升高是否与 2 型糖尿病有关,而与 2 型糖尿病的其他危险因素无关。
本研究共纳入 2009 年 1 月至 12 月期间在康伯斯三星医院健康筛查中心进行常规体检的 70063 名受试者(男 41391 名,女 28672 名;平均年龄 41.5 岁)。
研究对象的载脂蛋白 B/载脂蛋白 A-I 比值平均值为 0.66±0.18。2 型糖尿病的患病率随着载脂蛋白 B/载脂蛋白 A-I 比值四分位数的升高而增加(第 1 至 4 四分位数分别为 1.0%、1.6%、2.9%和 4.8%,P<0.001),稳态模型评估-胰岛素抵抗(HOMA2-IR)也呈四分位递增趋势(P<0.001)。载脂蛋白 B/载脂蛋白 A-I 比值与年龄、肥胖、血压、HOMA2-IR 值、空腹血糖水平和其他炎症标志物(包括高敏 C 反应蛋白和脂蛋白(a)水平)相关(均 P<0.001)。在多因素逻辑回归模型中,最高的载脂蛋白 B/载脂蛋白 A-I 比值四分位数与 2 型糖尿病相关,即使在控制了糖尿病的其他危险因素(如年龄、性别、BMI、收缩压、HOMA2-IR 值、高敏 C 反应蛋白水平、糖尿病家族史、代谢综合征的存在和常规脂质参数)后也是如此(比值比 1.31;95%置信区间 1.17-1.46,P<0.001)。
载脂蛋白 B/载脂蛋白 A-I 比值与 2 型糖尿病有关,而与糖尿病的其他危险因素和常规脂质参数无关。